The pharmaceutical industry relies heavily on a robust supply chain of high-quality intermediates to bring life-saving and life-enhancing drugs to market. Diethyl L-Glutamate Hydrochloride, identified by its CAS number 1118-89-4, is a significant player in this chain, serving as a crucial pharmaceutical intermediate. As a manufacturer based in China, we are a key contributor to this vital supply network.

Our Diethyl L-Glutamate Hydrochloride is a meticulously synthesized compound, characterized by its high purity (≥99.0% assay) and consistent quality. This makes it an indispensable ingredient for pharmaceutical companies engaged in the synthesis of various active pharmaceutical ingredients (APIs). Its primary utility lies in the development of Central Nervous System (CNS) drugs, including important anticonvulsant medications used to treat epilepsy. The reliability of our product ensures that pharmaceutical manufacturers can maintain the integrity and efficacy of their final drug products.

For companies actively seeking to buy this intermediate, understanding the supply chain dynamics is important. Partnering with a manufacturer that possesses advanced synthesis capabilities and stringent quality control measures is paramount. We pride ourselves on being such a supplier, offering competitive pricing and secure delivery to our global clientele. Whether you are involved in early-stage laboratory research, drug formulation, or large-scale API production, our Diethyl L-Glutamate Hydrochloride can meet your needs.

The journey of a pharmaceutical from concept to patient is complex, and the availability of critical intermediates like CAS 1118-89-4 is fundamental. We are committed to supporting the pharmaceutical industry by ensuring a stable and high-quality supply of this essential chemical. If you are interested in inquiring about the price, requesting a sample, or understanding our manufacturing capabilities, please do not hesitate to contact us. We are your trusted partner for pharmaceutical intermediates.